The WACC of Nirvana Life Sciences Inc (NIRV.CN) is 17.8%.
| Range | Selected | |
| Cost of equity | 20.50% - 24.90% | 22.70% |
| Tax rate | 25.90% - 26.50% | 26.20% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 16.1% - 19.4% | 17.8% |
| Category | Low | High |
| Long-term bond rate | 3.2% | 3.7% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 3.41 | 3.41 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 20.50% | 24.90% |
| Tax rate | 25.90% | 26.50% |
| Debt/Equity ratio | 0.35 | 0.35 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 16.1% | 19.4% |
| Selected WACC | 17.8% | |